Boston Scientific Approves 2026 Executive Bonus and Performance Share Plans
Boston Scientific Corporation has approved its 2026 Annual Bonus Plan, which will provide eligible employees, including named executive officers, with annual cash incentives based on performance metrics for the year beginning January 1, 2026. The bonus pool is determined by multiplying total target bonuses by a distribution percentage, which the Compensation Committee will set between 0% and 150% based on the company's global sales, adjusted earnings per share, operating income as a percent of sales, and corporate sustainability goals. Additionally, the company has adopted two new performance share programs for 2026: one based on relative total shareholder return compared to the S&P 500 Healthcare Index over three years, and another focused on organic net sales growth. These programs are similar to those implemented in the previous year.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000885725-25-000052), on November 19, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.